Texas AG Investigating Pharmaceutical Companies That Promote Hormone Blockers for Kids
Texas Attorney General Ken Paxton has announced an investigation into two pharmaceutical companies that allegedly promote the use of hormone blocking drugs for children.
The drugs are not approved by the Food and Drug Administration for this purpose.
Paxton’s office is looking into whether or not Endo Pharmaceuticals, Inc. and AbbVie Inc. violated the Texas Deceptive Trade Practices Act by promoting using the medications Supprelin LA and Lupron Depot for kids whose parents allege that they are transgender.
According to a press release from the Attorney General, “Supprelin LA and Lupron Depot are approved to treat children with Central Precocious Puberty (CPP), when the puberty process begins prematurely. And Vantas, along with other forms of Lupron, has been prescribed for palliative treatment of prostate cancer.
